ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies. Matsumoto A, Nakashima C, Kimura S, Sueoka E, et al. BMC Cancer 2021;21:584.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Matsumoto A, Nakashima C, Kimura S, Sueoka E, et al. ALDH2 polymorphism rs671 is a predictor of PD-1/PD-L1 inhibitor efficacy against thoracic malignancies. BMC Cancer 2021;21:584.
PMID: 34022841